Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:2,3,5-Trihydroxytoluene)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003565 AN005858 Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST003179 AN005222 Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST003144 AN005160 On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002792 AN004543 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002776 AN004519 Zebrafish Optic Nerve Regeneration, Tectum Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami LC-MS
ST002551 AN004200 Metabolomics dataset of CNTF induced axon regeneration in mice post optic nerve crush Eye tissue Mouse Eye disease University of Miami LC-MS
ST001788 AN002899 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University LC-MS
ST001788 AN002900 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University LC-MS
ST001549 AN002581 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University LC-MS
ST001205 AN002007 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001205 AN002007 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001033 AN001694 Determination of mode of action of anti-malalrial drugs using untargeted metabolomics Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST000539 AN000819 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash University LC-MS
ST000414 AN000656 Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences LC-MS
ST000403 AN000643 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences LC-MS
ST000311 AN000494 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida LC-MS
ST000311 AN000495 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida LC-MS
ST000311 AN000496 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida LC-MS
ST000311 AN000497 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida LC-MS
ST000291 AN000464 LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice Urine Human University of Florida LC-MS
  logo